{
  "paper": {
    "doi": null,
    "pmcid": "extracted_paper_1",
    "title": "The Role of Aurora Kinase A in HBV-Associated Hepatocellular Carcinomas: A Molecular and Immunohistochemical Study",
    "authors": [
      "Not specified"
    ],
    "journal": "Not specified",
    "year": null,
    "study_type": "case-control study",
    "eco_type": null
  },
  "extraction_provenance": {
    "extraction_pipeline": {
      "name": "medlit_pass1_extract",
      "version": "0.1.0",
      "git_commit": "777544707e2808fd01d9cb8fbe5dc1d74b29532b",
      "git_commit_short": "7775447",
      "git_branch": "main",
      "git_dirty": true,
      "repo_url": "https://github.com/org/medlit"
    },
    "models": {
      "llm": {
        "name": "claude-sonnet-4-20250514",
        "version": ""
      }
    },
    "prompt": {
      "version": "v1",
      "template": "medlit_extraction_v1",
      "checksum": "sha256:5bdf447f3cfe242d"
    },
    "execution": {
      "timestamp": "2026-02-27T16:19:01.364755Z",
      "hostname": "unknown",
      "python_version": "3.13.3",
      "duration_seconds": 51.85
    },
    "entity_resolution": null,
    "model_info": null
  },
  "entities": [
    {
      "id": "AURKA_protein",
      "class": "Protein",
      "name": "Aurora kinase A",
      "synonyms": [
        "AURKA"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": "HGNC:11393",
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "HBV_HCC_disease",
      "class": "Disease",
      "name": "hepatitis B virus-associated hepatocellular carcinoma",
      "synonyms": [
        "HBV-HCC",
        "HBV-related HCC"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": "C0019204",
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "PLK1_protein",
      "class": "Protein",
      "name": "Polo-like kinase 1",
      "synonyms": [
        "PLK1"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": "HGNC:9077",
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "P53_protein",
      "class": "Protein",
      "name": "p53",
      "synonyms": [
        "TP53"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": "HGNC:11998",
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "BRCA1_protein",
      "class": "Protein",
      "name": "breast cancer type 1 susceptibility protein",
      "synonyms": [
        "BRCA1"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": "HGNC:1100",
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "Cr_HCC_disease",
      "class": "Disease",
      "name": "cryptogenic hepatocellular carcinoma",
      "synonyms": [
        "Cr-HCC"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": "C0019204",
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "HCC_disease",
      "class": "Disease",
      "name": "hepatocellular carcinoma",
      "synonyms": [
        "HCC",
        "primary liver cancer"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": "C2239176",
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "P53Ser315_biomarker",
      "class": "Biomarker",
      "name": "Phospho-P53Ser315",
      "synonyms": [
        "phospho-p53Ser315"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "PLK1Thr210_biomarker",
      "class": "Biomarker",
      "name": "Phospho-PLK1Thr210",
      "synonyms": [
        "phospho-PLK1Thr210"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "CNV_mutation",
      "class": "Mutation",
      "name": "copy number variation",
      "synonyms": [
        "CNV"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "IHC_procedure",
      "class": "Procedure",
      "name": "immunohistochemistry",
      "synonyms": [
        "IHC",
        "immunohistochemical"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "atezolizumab_drug",
      "class": "Drug",
      "name": "atezolizumab",
      "synonyms": [],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": "1792776",
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "bevacizumab_drug",
      "class": "Drug",
      "name": "bevacizumab",
      "synonyms": [],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": "351181",
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "TACE_procedure",
      "class": "Procedure",
      "name": "transarterial chemoembolization",
      "synonyms": [
        "TACE"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "cell_cycle_progression_process",
      "class": "BiologicalProcess",
      "name": "cell cycle progression",
      "synonyms": [],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "centrosome_structure",
      "class": "AnatomicalStructure",
      "name": "centrosome",
      "synonyms": [],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "genomic_instability_process",
      "class": "BiologicalProcess",
      "name": "genomic instability",
      "synonyms": [
        "chromosomal instability"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "HBx_protein",
      "class": "Protein",
      "name": "hepatitis B viral protein HBx",
      "synonyms": [
        "HBx"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "MLN8237_drug",
      "class": "Drug",
      "name": "MLN8237",
      "synonyms": [
        "Alisertib"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": "1298331",
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "sorafenib_drug",
      "class": "Drug",
      "name": "Sorafenib",
      "synonyms": [],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": "608406",
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "MDM2_protein",
      "class": "Protein",
      "name": "MDM2",
      "synonyms": [],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": "HGNC:6973",
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "TMA_procedure",
      "class": "Procedure",
      "name": "tissue microarray",
      "synonyms": [
        "TMA"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "qPCR_procedure",
      "class": "Procedure",
      "name": "quantitative PCR",
      "synonyms": [
        "real-time PCR",
        "RT-PCR"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "FFPE_procedure",
      "class": "Procedure",
      "name": "formalin-fixed paraffin-embedded",
      "synonyms": [
        "FFPE"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    }
  ],
  "evidence_entities": [
    {
      "id": "extracted_paper_1:results:1:llm",
      "class": "Evidence",
      "entity_id": null,
      "paper_id": "extracted_paper_1",
      "text_span_id": "results_1",
      "text": "AURKA level was significantly increased in both test groups (p < 0.001). At the protein level, AURKA was significantly higher in both cancer groups compared to the control group (p < 0.001).",
      "confidence": 0.95,
      "extraction_method": "llm",
      "study_type": "case-control study",
      "eco_type": null,
      "source": "extracted"
    },
    {
      "id": "extracted_paper_1:results:2:llm",
      "class": "Evidence",
      "entity_id": null,
      "paper_id": "extracted_paper_1",
      "text_span_id": "results_2",
      "text": "Phospho-P53Ser315 levels were significantly higher in both HBV-HCC and Cr-HCC groups compared to the control group (p = 0.002 and p < 0.001, respectively). Cr-HCC cases also showed significantly higher levels compared to HBV-HCC (p = 0.025).",
      "confidence": 0.95,
      "extraction_method": "llm",
      "study_type": "case-control study",
      "eco_type": null,
      "source": "extracted"
    },
    {
      "id": "extracted_paper_1:results:3:llm",
      "class": "Evidence",
      "entity_id": null,
      "paper_id": "extracted_paper_1",
      "text_span_id": "results_3",
      "text": "For phospho-PLK1Thr210, Cr-HCC cases showed statistically higher expression compared to both the control group and HBV-HCC cases (p = 0.001).",
      "confidence": 0.95,
      "extraction_method": "llm",
      "study_type": "case-control study",
      "eco_type": null,
      "source": "extracted"
    },
    {
      "id": "extracted_paper_1:results:4:llm",
      "class": "Evidence",
      "entity_id": null,
      "paper_id": "extracted_paper_1",
      "text_span_id": "results_4",
      "text": "There was no increase in AURKA gene copy number among the groups (2\u2212\u2206\u2206Ct < 2).",
      "confidence": 0.9,
      "extraction_method": "llm",
      "study_type": "case-control study",
      "eco_type": null,
      "source": "extracted"
    },
    {
      "id": "extracted_paper_1:introduction:1:llm",
      "class": "Evidence",
      "entity_id": null,
      "paper_id": "extracted_paper_1",
      "text_span_id": "introduction_1",
      "text": "AURKA directly phosphorylates the Thr210 residue within the PLK1 kinase domain, initiating mitotic progression.",
      "confidence": 0.9,
      "extraction_method": "llm",
      "study_type": "case-control study",
      "eco_type": null,
      "source": "extracted"
    },
    {
      "id": "extracted_paper_1:introduction:2:llm",
      "class": "Evidence",
      "entity_id": null,
      "paper_id": "extracted_paper_1",
      "text_span_id": "introduction_2",
      "text": "Overexpression of AURKA has been shown to destabilize p53 through Ser315 phosphorylation, leading to loss of function, centrosome amplification, chromosomal instability, and oncogenic transformation.",
      "confidence": 0.9,
      "extraction_method": "llm",
      "study_type": "case-control study",
      "eco_type": null,
      "source": "extracted"
    },
    {
      "id": "extracted_paper_1:discussion:1:llm",
      "class": "Evidence",
      "entity_id": null,
      "paper_id": "extracted_paper_1",
      "text_span_id": "discussion_1",
      "text": "experimental studies have demonstrated that MLN8237 exhibits a strong synergistic effect with Sorafenib in HCC models.",
      "confidence": 0.85,
      "extraction_method": "llm",
      "study_type": "case-control study",
      "eco_type": null,
      "source": "extracted"
    }
  ],
  "relationships": [
    {
      "subject": "AURKA_protein",
      "predicate": "ASSOCIATED_WITH",
      "object": "HBV_HCC_disease",
      "evidence_ids": [
        "extracted_paper_1:results:1:llm"
      ],
      "source_papers": [
        "extracted_paper_1"
      ],
      "confidence": 0.95,
      "properties": {
        "expression_level": "increased"
      },
      "section": "results",
      "asserted_by": "llm",
      "resolution": null,
      "note": null
    },
    {
      "subject": "AURKA_protein",
      "predicate": "ASSOCIATED_WITH",
      "object": "Cr_HCC_disease",
      "evidence_ids": [
        "extracted_paper_1:results:1:llm"
      ],
      "source_papers": [
        "extracted_paper_1"
      ],
      "confidence": 0.95,
      "properties": {
        "expression_level": "increased"
      },
      "section": "results",
      "asserted_by": "llm",
      "resolution": null,
      "note": null
    },
    {
      "subject": "AURKA_protein",
      "predicate": "INCREASES_RISK",
      "object": "HCC_disease",
      "evidence_ids": [
        "extracted_paper_1:results:1:llm"
      ],
      "source_papers": [
        "extracted_paper_1"
      ],
      "confidence": 0.9,
      "properties": {
        "mechanism": "overexpression"
      },
      "section": "results",
      "asserted_by": "llm",
      "resolution": null,
      "note": null
    },
    {
      "subject": "AURKA_protein",
      "predicate": "REGULATES",
      "object": "PLK1_protein",
      "evidence_ids": [
        "extracted_paper_1:introduction:1:llm"
      ],
      "source_papers": [
        "extracted_paper_1"
      ],
      "confidence": 0.9,
      "properties": {
        "mechanism": "phosphorylation",
        "site": "Thr210"
      },
      "section": "introduction",
      "asserted_by": "llm",
      "resolution": null,
      "note": null
    },
    {
      "subject": "AURKA_protein",
      "predicate": "REGULATES",
      "object": "P53_protein",
      "evidence_ids": [
        "extracted_paper_1:introduction:2:llm"
      ],
      "source_papers": [
        "extracted_paper_1"
      ],
      "confidence": 0.9,
      "properties": {
        "mechanism": "phosphorylation",
        "site": "Ser315",
        "effect": "destabilization"
      },
      "section": "introduction",
      "asserted_by": "llm",
      "resolution": null,
      "note": null
    },
    {
      "subject": "P53Ser315_biomarker",
      "predicate": "INDICATES",
      "object": "HBV_HCC_disease",
      "evidence_ids": [
        "extracted_paper_1:results:2:llm"
      ],
      "source_papers": [
        "extracted_paper_1"
      ],
      "confidence": 0.95,
      "properties": {
        "expression_level": "elevated"
      },
      "section": "results",
      "asserted_by": "llm",
      "resolution": null,
      "note": null
    },
    {
      "subject": "P53Ser315_biomarker",
      "predicate": "INDICATES",
      "object": "Cr_HCC_disease",
      "evidence_ids": [
        "extracted_paper_1:results:2:llm"
      ],
      "source_papers": [
        "extracted_paper_1"
      ],
      "confidence": 0.95,
      "properties": {
        "expression_level": "elevated"
      },
      "section": "results",
      "asserted_by": "llm",
      "resolution": null,
      "note": null
    },
    {
      "subject": "PLK1Thr210_biomarker",
      "predicate": "INDICATES",
      "object": "Cr_HCC_disease",
      "evidence_ids": [
        "extracted_paper_1:results:3:llm"
      ],
      "source_papers": [
        "extracted_paper_1"
      ],
      "confidence": 0.95,
      "properties": {
        "expression_level": "elevated"
      },
      "section": "results",
      "asserted_by": "llm",
      "resolution": null,
      "note": null
    },
    {
      "subject": "MLN8237_drug",
      "predicate": "TREATS",
      "object": "HCC_disease",
      "evidence_ids": [
        "extracted_paper_1:discussion:1:llm"
      ],
      "source_papers": [
        "extracted_paper_1"
      ],
      "confidence": 0.85,
      "properties": {
        "combination": "with sorafenib",
        "effect": "synergistic"
      },
      "section": "discussion",
      "asserted_by": "llm",
      "resolution": null,
      "note": null
    },
    {
      "subject": "atezolizumab_drug",
      "predicate": "TREATS",
      "object": "HCC_disease",
      "evidence_ids": [],
      "source_papers": [
        "extracted_paper_1"
      ],
      "confidence": 0.8,
      "properties": {
        "combination": "with bevacizumab"
      },
      "section": "introduction",
      "asserted_by": "llm",
      "resolution": null,
      "note": null
    },
    {
      "subject": "AURKA_protein",
      "predicate": "CAUSES",
      "object": "genomic_instability_process",
      "evidence_ids": [
        "extracted_paper_1:introduction:2:llm"
      ],
      "source_papers": [
        "extracted_paper_1"
      ],
      "confidence": 0.9,
      "properties": {
        "mechanism": "overexpression"
      },
      "section": "introduction",
      "asserted_by": "llm",
      "resolution": null,
      "note": null
    },
    {
      "subject": "AURKA_protein",
      "predicate": "REGULATES",
      "object": "cell_cycle_progression_process",
      "evidence_ids": [
        "extracted_paper_1:introduction:1:llm"
      ],
      "source_papers": [
        "extracted_paper_1"
      ],
      "confidence": 0.9,
      "properties": {
        "phase": "G2/M transition"
      },
      "section": "introduction",
      "asserted_by": "llm",
      "resolution": null,
      "note": null
    },
    {
      "subject": "cryptogenic hepatocellular carcinoma",
      "predicate": "SAME_AS",
      "object": "Cr_HCC_disease",
      "evidence_ids": [],
      "source_papers": [
        "extracted_paper_1"
      ],
      "confidence": 1.0,
      "properties": {},
      "section": "methods",
      "asserted_by": "llm",
      "resolution": null,
      "note": "Cr-HCC is the abbreviation for cryptogenic hepatocellular carcinoma"
    }
  ],
  "notes": [
    "This study demonstrates differential AURKA substrate activation patterns between HBV-associated and cryptogenic hepatocellular carcinoma, suggesting distinct therapeutic targets for each subtype.",
    "The study was limited by RNA degradation in FFPE samples, requiring reliance on immunohistochemical analysis rather than gene expression studies.",
    "No significant AURKA copy number variations were detected in either HCC subtype, suggesting that overexpression rather than gene amplification drives AURKA activity in HCC."
  ]
}